Selected article for: "high risk and residual risk"

Author: Nelson, Monica E.; Jester, Dylan J.; Petkus, Andrew J.; Andel, Ross
Title: Cognitive Reserve, Alzheimer’s Neuropathology, and Risk of Dementia: A Systematic Review and Meta-Analysis
  • Cord-id: 0fjhdpac
  • Document date: 2021_1_8
  • ID: 0fjhdpac
    Snippet: Cognitive reserve (CR) may reduce the risk of dementia. We summarized the effect of CR on progression to mild cognitive impairment (MCI) or dementia in studies accounting for Alzheimer’s disease (AD)-related structural pathology and biomarkers. Literature search was conducted in Web of Science, PubMed, Embase, and PsycINFO. Relevant articles were longitudinal, in English, and investigating MCI or dementia incidence. Meta-analysis was conducted on nine articles, four measuring CR as cognitive r
    Document: Cognitive reserve (CR) may reduce the risk of dementia. We summarized the effect of CR on progression to mild cognitive impairment (MCI) or dementia in studies accounting for Alzheimer’s disease (AD)-related structural pathology and biomarkers. Literature search was conducted in Web of Science, PubMed, Embase, and PsycINFO. Relevant articles were longitudinal, in English, and investigating MCI or dementia incidence. Meta-analysis was conducted on nine articles, four measuring CR as cognitive residual of neuropathology and five as composite psychosocial proxies (e.g., education). High CR was related to a 47% reduced relative risk of MCI or dementia (pooled-hazard ratio: 0.53 [0.35, 0.81]), with residual-based CR reducing risk by 62% and proxy-based CR by 48%. CR protects against MCI and dementia progression above and beyond the effect of AD-related structural pathology and biomarkers. The finding that proxy-based measures of CR rivaled residual-based measures in terms of effect on dementia incidence underscores the importance of early- and mid-life factors in preventing dementia later.

    Search related documents:
    Co phrase search for related documents
    • actual difference and longitudinal study: 1
    • actual difference and magnetic resonance: 1, 2
    • ad biomarker and longitudinal study: 1, 2
    • ad dementia and magnetic resonance: 1, 2, 3, 4
    • ad diagnosis and magnetic resonance: 1, 2, 3, 4
    • ad disease and longitudinal study: 1, 2, 3
    • ad disease and magnetic resonance: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
    • ad neuropathology and magnetic resonance: 1
    • adas cog scale cognitive subscale and magnetic resonance: 1
    • additional sub and longitudinal study: 1
    • adequate information and longitudinal study: 1
    • longitudinal cohort and magnetic resonance: 1, 2, 3, 4, 5, 6, 7, 8
    • longitudinal cohort study and magnetic resonance: 1, 2, 3, 4, 5, 6, 7
    • longitudinal study and magnetic resonance: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
    • longitudinal study and magnetic resonance imaging: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17